A prospective, open-label, proof-of-concept pilot study of the effects of a single one-hour target-controlled remifentanil infusion on pain in 24 patients with persistent postsurgical pain.
Phase of Trial: Phase IV
Latest Information Update: 30 May 2016
At a glance
- Drugs Remifentanil (Primary)
- Indications Postoperative pain
- Focus Proof of concept; Therapeutic Use
- 30 May 2016 New trial record